# John N. Allan, M.D. – FDA 483, Jun 22, 2026

Source: https://www.keypedia.com/records/483/john-n-allan-md/d1f65608-d853-4900-8911-bc4be9c1f640

> FDA 483 for John N. Allan, M.D. on June 22, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: John N. Allan, M.D.
- Inspection Date: 2026-06-22
- Product Type: drugs
- Office Name: New York District Office
- Summary: An FDA inspection of John N. Allan, M.D., a Sponsor-Investigator in New York, revealed a significant regulatory lapse. The firm failed to submit required annual reports for two Investigational New Drugs (INDs) within the mandated 60-day timeframe following their anniversary dates. This indicates a failure to comply with regulatory reporting requirements for clinical investigations.

## Related Officers

- [Omadevi Somai](https://www.keypedia.com/people/omadevi-somai/8a6212bf-2dfa-44ea-bd2f-f2aeb78aa1bd)

Company: https://www.keypedia.com/companies/john-n-allan-md/b9a584db-38d4-4aa2-8a63-6ab9fbab81c4

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d